A microbial molecule is being studied for its potential to address diabetes. The molecule, which is linked to gut bacteria, may offer a new therapeutic option for stopping diabetes-induced complications, such as kidney fibrosis, and could also be used to treat obesity. However, it is unclear what specific treatment or application is being developed, with various possibilities including a new drug, gut bacteria peptides, islet organoids, or fecal transplantation.